ICAM1 and atherosclerosis: Atherosclerosis and atherogenic diet-mediated inflammation are also prevented by its anti-inflammatory impact, which also appears to be caused by reducing the activation of inflammatory markers, such as NF-κB, ICAM-1, and pro-inflammatory cytokines.